Nath Bio-Genes (India) Limited
NATHBIOGEN.BO
Bombay Stock Exchange165.00
INR
-2.95
- -
Nath Bio-Genes (India) Limited
NATHBIOGEN.BO
(Bombay Stock Exchange)
Recent
price
165.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Nath Bio-Genes (India) Limited, incorporated in 1993 and headquartered in Aurangabad, Maharashtra, operates as a leading agri-biotech company focused on the research, production, processing, and marketing of hybrid, genetically modified (GM), and varietal seeds for field crops including cotton, paddy, and maize; vegetable crops such as tomatoes, okra, brinjal, cauliflower, cabbage, and chillies; and plant nutrient supplements like WINALL granules and WINPRO GOLI organic fertilizers. The company maintains an extensive R&D network across eight stations and over 300 acres in diverse agro-climatic zones, collaborating with international institutions such as the Chinese Academy of Agricultural Sciences, CIMMYT, IRRI, and ICRISAT, while producing seeds on more than 30,000 acres through partnerships with 25,000 growers in states including Maharashtra, Andhra Pradesh, Gujarat, Karnataka, Rajasthan, Madhya Pradesh, Odisha, Uttar Pradesh, and Tamil Nadu. It processes seeds at major facilities in Aurangabad and Nizamabad, supported by ten automated plants equipped with pre-cleaners, graders, gravity separators, treaters, and packing systems, and distributes over 350 products through 17 branch offices, 1,000 distributors, and 20,000 dealers across 17 Indian states, with international operations targeting Asia, Africa, the Middle East, and a recent joint venture, Nath Bio-Genes CA LLC in Uzbekistan established in 2025 holding a 90% stake. Recent developments include the launch of high-performing cotton hybrid seeds Sanket and Daksh in 2019-20, which ranked among the top three in ICAR trials across multiple geographies; introduction of hybrid paddy varieties Dhoom, Dhadak, and Dhadak Gold in 2021-22; addition of organic fertilizers WINALL granules and WINPRO GOLI in 2023-24 to enhance soil nutrition; and robust financial performance with September 2025 standalone net sales rising 23.5% year-over-year to Rs 39.77 crore alongside a 37.7% increase in EBITDA to Rs 9.13 crore. As the flagship of the Nath Group and BSE-listed under ticker NATHBIOGEN.BO, the company emphasizes farmer-centric programs like Nath Farmer Advisors, multi-location trials, large-scale demonstrations, and stewardship initiatives to boost yields, combat climate challenges, and promote sustainable practices serving over five million farmers domestically and expanding globally.